This is consistent with previous findings that insulin therapy can normalize CD8+ T-cell profiles in a rat STZ model in the liver by reducing antigen load and hyperglycemia-associated inflammation (Lee et al., 2016). Here, CD8A is linked to Hyperglycemia.